Why this drug is interesting

Fentanyl is roughly a hundred times as potent as morphine, highly lipid-soluble, and — unlike morphine — does not cause histamine release. That last property is why it is the opioid used at induction of anaesthesia: it provides analgesia and blunts the sympathetic response to laryngoscopy without dropping the blood pressure through vasodilatation.

It is also the drug at the centre of the synthetic opioid crisis, and the reason a generation of naloxone teaching has been revised. Those two roles — a controlled, precisely titrated drug at induction, and an uncontrolled adulterant of street heroin — are the same molecule.

Dosing

The licensed indications are analgesia during short surgical procedures, high-dose use as an analgesic and respiratory depressant in patients requiring assisted ventilation, neuroleptanalgesia, and "the treatment of severe pain, such as the pain of myocardial infarction."¹

Adult intravenous doses
Setting	Initial	Supplemental
Spontaneous respiration	50–200 µg	50 µg
Assisted ventilation	300–3500 µg	100–200 µg

Doses above 200 micrograms are for use in anaesthesia only — a labelled restriction governing the first row of the table above.

Children 2–11 years
Setting	Initial	Supplemental
Spontaneous respiration	1–3 µg/kg	1–1.25 µg/kg
Assisted ventilation	1–3 µg/kg	1–1.25 µg/kg

Special populations

Reduce the initial dose in the elderly (over 65) and in debilitated patients, and take the effect of that dose into account when deciding supplements¹
Obesity — the label is directive, not advisory: "in obese patients there is a risk of overdosing if the dose is calculated based on body weight. Obese patients should have dosage calculated according to their estimated lean body mass."¹
The label instructs that a strategy for ending opioid treatment should be discussed with patients before starting, to minimise the risk of addiction and withdrawal

Chest wall rigidity

This is a Very Common labelled adverse reaction — not a curiosity

The SmPC's adverse reaction table lists muscle rigidity (which may also involve the thoracic muscles) in the Very Common (≥1/10) frequency category.¹ Most textbook accounts treat chest wall rigidity as a rare phenomenon of high-dose anaesthetic practice; the label does not.

The general adult requirement is short and absolute: "Fentanyl should be given only in an environment where the airway can be controlled and by personnel who can control the airway." The label goes further for children, directing that techniques involving analgesia in a spontaneously breathing child be used "only… as part of an anaesthetic technique, or given as part of a sedation/analgesia technique with experienced personnel in an environment that can manage sudden chest wall rigidity requiring intubation, or apnoea requiring airway support."¹

Clinically, it presents as a patient who becomes progressively impossible to bag-mask ventilate shortly after a fentanyl dose — chest compliance falls, and the glottis may close as well. It is dose-related and more likely with rapid administration.

Use at intubation

Laryngoscopy produces an intense sympathetic response — tachycardia and hypertension — which is undesirable in raised intracranial pressure, aortic dissection, subarachnoid haemorrhage and ischaemic heart disease. Fentanyl blunts it, which is why it commonly appears as the first of the three drugs in a rapid sequence induction.

Given the very common rigidity effect, fentanyl at induction should be given before, not instead of, a plan for paralysis — and slowly enough that rigidity declares itself while there is still time to act.

Pharmacology

Mechanism

A pure μ opioid receptor agonist. Its high lipid solubility gives it rapid central nervous system penetration and a fast onset; the absence of histamine release distinguishes it from morphine and accounts for its cardiovascular stability.

Kinetics — and the accumulation trap

Onset: Within a few minutes intravenously
Offset after a single bolus: By redistribution into fat and muscle, not by elimination
Terminal half-life: Considerably longer than the duration of a single dose
Context-sensitive half-time: Rises markedly with repeated dosing or infusion
Metabolism: Hepatic, principally CYP3A4

Interactions

CYP3A4 inhibitors — clarithromycin, erythromycin, ritonavir, ketoconazole, diltiazem — increase fentanyl exposure. Concomitant benzodiazepines, gabapentinoids and alcohol substantially increase the risk of respiratory depression.

Adverse effects

Muscle rigidity, including thoracic — very common
Nausea and vomiting — very common
Respiratory depression and apnoea; laryngospasm and bronchospasm
Bradycardia, tachycardia, arrhythmia; hypotension and hypertension
Sedation, dizziness, dyskinesia; agitation
Convulsions, myoclonus and loss of consciousness (frequency not known)
Cardiac arrest (frequency not known)
Pruritus; hypersensitivity including anaphylaxis
Drug dependence and withdrawal syndrome

Overdose management is airway support and ventilation first, with naloxone titrated to respiratory adequacy rather than to consciousness. The UK approach is set out in the RCEM and NPIS opioid toxicity guideline — titrate from 100 micrograms in the non-peri-arrest patient, and anticipate that potent synthetic opioids may require larger total doses and an infusion.

Critical appraisal

Chest wall rigidity is systematically under-taught relative to its labelled frequency. A very common adverse effect that can make a patient unventilatable deserves more than a footnote, and most clinicians first encounter it as a surprise rather than as a recognised pattern.
"Short-acting" is the most misleading thing said about this drug. It is short-acting once. The redistribution model is rarely explained, so the accumulation on repeated dosing is experienced as a mystery rather than as arithmetic.
Blunting the pressor response is well-reasoned and thinly evidenced. That laryngoscopy causes a catecholamine surge is not in doubt; that suppressing it improves outcomes in head injury or dissection is inferred rather than demonstrated. It is a reasonable inference — but it should not be presented as established.
Its two lives should be taught together. The precision with which fentanyl is titrated in theatre and the unpredictability with which its analogues are encountered in overdose are the same pharmacology under different conditions of dosing and purity, and understanding one illuminates the other.

References

1
Fentanyl 50 microgram/ml Injection — Summary of Product Characteristics, hameln pharma ltd. electronic Medicines Compendium. Sections 4.1, 4.2, 4.4, 4.8. Verified 24 Aug 2026. Compare Sublimaze, emc.
2
Royal College of Emergency Medicine and National Poisons Information Service. Guideline for the Assessment and Management of Acute Opioid Toxicity in Adults in the Emergency Department, April 2024. rcem.ac.uk · Emerg Med J 2024;41(7):440–5. PubMed
3
Royal College of Anaesthetists and Difficult Airway Society. NAP4: Major complications of airway management in the United Kingdom. nationalauditprojects.org.uk
4
TOXBASE — opioids; fentanyl and fentanyl analogues. National Poisons Information Service. toxbase.org (NHS login required.)
5
Fentanyl — dosing and safety monograph. BNF, NICE. bnf.nice.org.uk

Fentanyl

At a glance